A view from the Center

>

Deloitte's Life Sciences & Health Care Blog

Filter by category or month:

Can our paper-based clinical-trial model make the jump to the virtual world?

by Dawn Anderson, Managing director, Deloitte Consulting LLP

I entered the pharmaceutical sector 32 years ago as a clinical research associate. In all that time, there has been surprisingly little change to the way biopharmaceutical companies and contract research organizations conduct clinical trials. While digital technology is widely available to the general population, it generally has not made its way into clinical trials.

Read more

Here’s how to make virtual health a pillar of your health plan members’ experience

by Felix Matthews, MD, MBA and Ken Abrams, MD, MBA, Deloitte Consulting LLP

Nearly all health plans (94 percent) offer virtual health services, and 96 percent expect their reliance on this technology will grow, according to the results of a survey conducted by America’s Health Insurance Plans (AHIP).1 However, despite being widely available, virtual health has generally not been embraced by health plan members. One of the most formidable barriers to adoption might be the members themselves.

Read more

For health plans, next-gen workers may be just as critical as next-gen technology

by Eileen Schreiber Radis, Deloitte Consulting LLP, and Nigel Lennox Ferguson, Deloitte Consulting LLP

Many health plans are investing in next-generation technologies, but they might not yet have a strategy for building a next-generation workforce. The nature of work in changing in health and in all industries. This is being driven by automation and technology as well as increased consumerism, generational shifts, and open talent models. We expect the future of work will impact every health plan employee.

Read more

When building a virtual health portfolio, behavioral health might be the perfect place to start

by Bill Fera, Principal, Deloitte Consulting LLP, and Felix Matthews, MD, MBA, Managing Director, Deloitte Consulting LLP

Although still in its infancy, virtual health has already begun to transform patient care by improving access to care, extending the reach of clinical management, and making it easier to gather, store and share information.1As health plans, health systems, and physician groups develop their enterprise-wide virtual health strategies, behavioral health care is  increasingly being seen as an appealing starting point for its impact on total medical expenses.

Read more

As interest in oncology grows, real-world data could help biopharma firms improve clinical research, reduce costs

by Brett J. Davis, General Manager & Principal | ConvergeHealth by Deloitte, Deloitte Consulting LLP

Early this year, I attended the annual J.P. Morgan Healthcare conference where investors and biopharmaceutical company executives were excited about the growth of personalized therapies—particularly in oncology. This optimism was somewhat tempered by some of the many challenges in oncology research and development (R&D) and bringing high-cost therapies to market. However, advances in digital health,

Read more

Health and research in 2019: Five trends to watch

by Margaret Anderson, Managing Director, Deloitte Consulting LLP

There is something about a new year that gives us a clearer vantage point on the trends that might lie ahead. A new year might be an artificial demarcation point, but I use it to reflect on where the health care and innovation market is now, and where it could be headed.

The exponential promise that exists in the life sciences and health care sectors is unprecedented.

Read more